Crossmark

Peer involvement and cross-sector efforts in establishing integrated treatment of hepatitis C virus infection for people with substance use disorders: experiences from Norway

Crossref DOI link: https://doi.org/10.1186/s13011-019-0245-y

Published Online: 2019-12-21

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

,

Lygren, Ole Jørgen

Bjørnestad, Ronny

Løberg, Else-Marie

Bonnier, Martine Lepsøy

Buljovcic, Vibeke Bråthen

Johansson, Kjell Arne

Fadnes, Lars T. https://orcid.org/0000-0001-8757-2092
Funding

Funding for this research was provided by:

Norges Forskningsråd (269855)

Helse Vest (Åpen prosjektstøtte)
License Information

Text and Data Mining valid from 2019-12-01

Version of Record valid from 2019-12-21
More Information

Article History

Received: 3 June 2019

Accepted: 4 December 2019

First Online: 21 December 2019

Ethics approval and consent to participate

: The INTRO-HCV study has been approved by regional ethical committee (no. 2017/51/REK Vest, dated 29.03.2017/20.04.2017). Informed consent is obtained from participants.

: All authors have approved the final manuscript.

: The authors EML, MLB, VBB, KAJ, LTF have no competing interests. OJL and RB have received some funding from AbbVie, Gilead and MSD.

Document is current

Any future updates will be listed below